Clinical Research Directory
Browse clinical research sites, groups, and studies.
Dietary Intervention for NSCLC Patients Treated With ICI
Sponsor: Centre hospitalier de l'Université de Montréal (CHUM)
Summary
This is a single-center randomized trial in patients with non-small cell lung cancer (NSCLC) treated with immune checkpoint inhibition. Patients will receive standard-of-care immune checkpoint inhibitor (ICI) therapy alone or in combination with a dietary intervention.
Official title: Randomized Dietary Intervention to Improve Fiber Intake in Patients With Non-small Cell Lung Cancer Treated With Immune Checkpoint Inhibitor Therapy
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
80
Start Date
2023-04-27
Completion Date
2026-03-30
Last Updated
2024-08-12
Healthy Volunteers
No
Conditions
Interventions
increasing total fiber intake
Patients in the intervention arm will complete a dietary survey and be counselled on increasing their total fiber intake.
Locations (1)
Centre hospitalier de l'Université de Montréal (CHUM)
Montreal, Quebec, Canada